총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Envista Holdings Corp (NVST), 포함 36 건 매수 및 11 건 매도. 내부자 매수 총액은 $7.05M 내부자 매도 총액은 $3.39M.
최근 활동이 있는 주요 내부자에는 Hammes Eric D., Keel Paul A, Nance Mark E. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.
내부자 거래 내역 — NVST
| 날짜 |
이름 |
직책 |
거래 유형 |
주식수 |
평균 가격 |
금액 |
보유 주식수 |
| 2026-02-25 |
Hammes Eric D. |
Chief Financial Officer |
RSU 부여 |
29,225 |
- |
- |
29,225 |
| 2026-02-25 |
Keel Paul A |
Chief Executive Officer |
RSU 부여 |
115,320 |
$29.59 |
$3.41M |
115,320 |
| 2026-02-25 |
Nance Mark E |
General Counsel |
RSU 부여 |
23,070 |
- |
- |
23,070 |
| 2026-02-25 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
RSU 부여 |
10,770 |
- |
- |
10,770 |
| 2026-02-25 |
Kaabi Faez C |
Chief Accounting Officer |
RSU 원천징수 |
4,964 |
$29.59 |
$146.88K |
45,032 |
| 2026-02-25 |
Befidi Robert |
President, Diagnostics |
RSU 부여 |
13,845 |
- |
- |
13,845 |
| 2026-02-25 |
Nilsson Stefan |
President, Nobel Biocare |
RSU 부여 |
13,845 |
- |
- |
13,845 |
| 2026-02-25 |
Acurio Veronica |
President, Orthodontics |
RSU 부여 |
13,845 |
- |
- |
13,845 |
| 2026-02-10 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
옵션 행사 (매도) |
5,634 |
$15.97 |
$89.97K |
- |
| 2026-02-01 |
Hammes Eric D. |
Chief Financial Officer |
RSU 부여 |
1,119 |
- |
- |
1,119 |
| 2026-02-01 |
Keel Paul A |
Chief Executive Officer |
RSU 부여 |
4,091 |
- |
- |
4,091 |
| 2026-02-01 |
Nance Mark E |
General Counsel |
RSU 부여 |
2,006 |
- |
- |
7,587 |
| 2026-02-01 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
RSU 부여 |
2,919 |
- |
- |
29,357 |
| 2026-02-01 |
Kaabi Faez C |
Chief Accounting Officer |
RSU 부여 |
1,186 |
- |
- |
5,040 |
| 2026-02-01 |
Befidi Robert |
President, Diagnostics |
RSU 부여 |
998 |
- |
- |
2,149 |
| 2026-02-01 |
Acurio Veronica |
President, Orthodontics |
RSU 부여 |
998 |
- |
- |
998 |
| 2025-11-01 |
Keel Paul A |
Chief Executive Officer |
RSU 원천징수 |
54,097 |
$20.35 |
$1.1M |
347,555 |
| 2025-08-25 |
Hammes Eric D. |
Chief Financial Officer |
RSU 원천징수 |
7,654 |
$21.12 |
$161.65K |
96,788 |
| 2025-08-25 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
정보 매도 |
15,000 |
$21.60 |
$324K |
32,382 |
| 2025-08-25 |
Befidi Robert |
President, Diagnostics |
RSU 원천징수 |
3,454 |
$21.12 |
$72.95K |
45,504 |
| 2025-08-25 |
Nilsson Stefan |
President, Nobel Biocare |
RSU 원천징수 |
804 |
$21.12 |
$16.98K |
54,941 |
| 2025-08-25 |
Acurio Veronica |
President, Orthodontics |
RSU 원천징수 |
5,422 |
$21.12 |
$114.51K |
50,323 |
| 2025-07-14 |
Pierce James Andrew |
Director |
알 수 없음 |
- |
- |
- |
- |
| 2025-07-14 |
Pierce James Andrew |
Director |
RSU 부여 |
9,155 |
- |
- |
9,155 |
| 2025-06-10 |
Tsingos Christine A |
Director |
RSU 부여 |
10,450 |
- |
- |
50,600 |
| 2025-06-10 |
Raskas Daniel |
Director |
RSU 부여 |
10,450 |
- |
- |
44,680 |
| 2025-06-10 |
Gallahue Kieran |
Director |
RSU 부여 |
10,450 |
- |
- |
44,680 |
| 2025-06-10 |
Huennekens R Scott |
Director |
RSU 부여 |
14,370 |
- |
- |
69,520 |
| 2025-06-10 |
Jain Vivek |
Director |
RSU 부여 |
10,450 |
- |
- |
43,615 |
| 2025-06-10 |
Carruthers Wendy |
Director |
RSU 부여 |
10,450 |
- |
- |
50,610 |
| 2025-06-10 |
Hulit Barbara B. |
Director |
RSU 부여 |
10,450 |
- |
- |
79,820 |
| 2025-05-25 |
Keel Paul A |
Chief Executive Officer |
RSU 원천징수 |
12,787 |
$16.72 |
$213.8K |
401,652 |
| 2025-02-26 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
RSU 부여 |
8,475 |
- |
- |
47,382 |
| 2025-02-25 |
Hammes Eric D. |
Chief Financial Officer |
RSU 부여 |
28,995 |
- |
- |
28,995 |
| 2025-02-25 |
Keel Paul A |
Chief Executive Officer |
RSU 부여 |
153,660 |
$20.66 |
$3.17M |
153,660 |
| 2025-02-25 |
Nance Mark E |
General Counsel |
RSU 부여 |
33,455 |
- |
- |
33,455 |
| 2025-02-25 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
RSU 부여 |
15,615 |
- |
- |
15,615 |
| 2025-02-25 |
Kaabi Faez C |
Chief Accounting Officer |
RSU 부여 |
22,600 |
$20.66 |
$466.92K |
22,600 |
| 2025-02-25 |
Befidi Robert |
President, Diagnostics |
RSU 부여 |
18,960 |
- |
- |
18,960 |
| 2025-02-25 |
Nilsson Stefan |
President, Nobel Biocare |
RSU 부여 |
18,960 |
- |
- |
18,960 |
| 2025-02-25 |
Acurio Veronica |
President, Orthodontics |
RSU 부여 |
18,960 |
- |
- |
18,960 |
| 2025-02-01 |
Nance Mark E |
General Counsel |
RSU 부여 |
965 |
- |
- |
5,581 |
| 2025-02-01 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
RSU 부여 |
3,152 |
- |
- |
26,438 |
| 2025-02-01 |
Kaabi Faez C |
Chief Accounting Officer |
RSU 부여 |
689 |
- |
- |
3,854 |
| 2025-02-01 |
Befidi Robert |
President, Diagnostics |
RSU 부여 |
1,151 |
- |
- |
1,151 |
| 2024-11-18 |
Nilsson Stefan |
President, Nobel Biocare |
알 수 없음 |
- |
- |
- |
45,455 |
| 2024-11-18 |
Acurio Veronica |
President, Orthodontics |
알 수 없음 |
- |
- |
- |
45,455 |
| 2024-11-01 |
Keel Paul A |
Chief Executive Officer |
RSU 원천징수 |
53,996 |
$20.94 |
$1.13M |
348,609 |
| 2024-09-17 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
RSU 원천징수 |
812 |
$19.00 |
$15.43K |
42,720 |
| 2024-08-25 |
Hammes Eric D. |
Chief Financial Officer |
RSU 부여 |
64,175 |
- |
- |
88,707 |
■ 정보 기반 — 공개 시장 거래 (가장 중요)
■ 비정보 매수 — 보상, 옵션 행사, 전환
■ 비정보 매도 — 세금 원천징수, 부여 매도
■ 중립 — 증여, 신탁, 만료
